You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for URECHOLINE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for URECHOLINE

Vendor Vendor Homepage Vendor Sku API Url
Molport ⤷  Get Started Free MolPort-003-666-134 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A832139 ⤷  Get Started Free
Enamine ⤷  Get Started Free EN300-51035 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS006230324 ⤷  Get Started Free
TimTec ⤷  Get Started Free SBB070369 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0622944 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for URECHOLINE

Last updated: July 30, 2025


Introduction

Urecholine, the trade name for the active pharmaceutical ingredient (API) Bethanechol Chloride, is primarily prescribed for stimulating bladder contractions in cases of urinary retention and certain gastrointestinal conditions. As a cholinergic agonist, Bethanechol mimics the neurotransmitter acetylcholine, inducing smooth muscle contractions within the urinary and gastrointestinal tracts. The global demand for Urecholine necessitates reliable, high-quality bulk API sourcing, emphasizing financial viability, regulatory compliance, and supply chain stability.

This report delineates the key sources for bulk Bethanechol Chloride API, analyzing manufacturer profiles, geographic distribution, regulatory status, and considerations critical for pharmaceutical companies and distributors.


Global Market Overview for Bethanechol Chloride API

The Bethanechol Chloride API market has traditionally been concentrated in regions with well-established pharmaceutical manufacturing capabilities, notably India, China, and Western Europe. These regions benefit from a robust chemical synthesis infrastructure, stringent quality controls, and proximity to regulatory agencies such as the U.S. FDA and EMA.

Major API Manufacturers for Bethanechol Chloride

1. Indian Pharmaceutical Manufacturers

India remains the dominant supplier of generic APIs, including Bethanechol Chloride, driven by low manufacturing costs and expanding GMP-compliant facilities:

  • Shilpa Medicare Ltd.
    Shilpa Medicare is among India's leading API manufacturers, with approval from major regulatory bodies. Its facilities produce Bethanechol Chloride under stringent quality standards, catering to both domestic and export markets.

  • Aarti Drugs Ltd.
    Recognized for comprehensive API production, Aarti Drugs manufactures Bethanechol Chloride at cGMP-certified plants, offering large-scale supply options.

  • Citius Pharmaceuticals (Note: Not to be confused with the U.S. biotech company)
    Focused on cholinergic agents, with capabilities for Bethanechol Chloride, complying with international standards.

2. Chinese API Producers

China's chemical industry has expanded significantly, with several API producers offering Bethanechol Chloride:

  • Zhejiang Beta Pharmaceutical Co., Ltd.
    Specializes in cholinergic and gastrointestinal agents. Certified for GMP, ISO, and CE standards, serving global markets.

  • Ningbo Inno Pharmchem Co., Ltd.
    Offers Bethanechol Chloride with extensive manufacturing experience and certifications suitable for export to North America and Europe.

3. European Manufacturers

European companies tend to focus on high-quality, high-value APIs with rigorous regulatory adherence:

  • Merk Serono (Merck KGaA)
    Historically involved in cholinergic drugs, primarily for research purposes; however, commercial-grade Bethanechol Chloride APIs are less common in this region.

  • SMI (Serbia)
    A smaller but compliant regional supplier, offering Bethanechol Chloride API conforming to European pharmacopoeias.


Regulatory and Quality Considerations

Reliable API sourcing hinges on rigorous quality assurance, regulatory compliance, and validated manufacturing processes. Key considerations include:

  • GMP Certification
    Ensures the API meets Good Manufacturing Practice standards, an essential requirement for pharmaceutical manufacturing.

  • Regulatory Approvals
    Suppliers compliant with FDA, EMA, and other regional authorities facilitate smoother approval processes and reduce compliance risks.

  • Certificate of Analysis (CoA)
    Suppliers must provide comprehensive testing documentation, including impurity profiles, residual solvents, and potency.

  • Quality Certifications
    ISO 9001, ISO 14001, and other environmental and quality management standards underscore supplier reliability.


Supply Chain and Sourcing Challenges

  • Price Fluctuations
    Variability in raw material costs, geopolitical factors, and currency fluctuations influence API pricing.

  • Supply Continuity
    Dependence on single-source suppliers introduces risk. Diversification strategies are recommended to mitigate shortages.

  • Regulatory Hurdles
    Import/export restrictions and certification updates must be monitored regularly.

  • Lead Times
    Sufficient lead times are necessary due to batch manufacturing schedules and shipping logistics.

Emerging Trends in API Sourcing for Bethanechol Chloride

  • Contract Manufacturing and Long-term Partnerships
    To ensure consistent supply, pharmaceutical companies increasingly partner with established API manufacturers on long-term contracts.

  • Quality by Design (QbD) Approaches
    Suppliers adopting QbD procedures can provide APIs with minimized impurities, aligning with regulatory expectations.

  • Sustainability Initiatives
    Eco-friendly manufacturing practices are gaining importance, influencing supplier selection.

Conclusion

Securing a reliable bulk API source for Urecholine (Bethanechol Chloride) involves evaluating manufacturer reputation, regulatory compliance, quality standards, and supply chain robustness. Indian and Chinese suppliers offer cost-effective bulk options, while European producers—though fewer—focus on high-quality standards suited for markets with stringent regulations.

Choosing the optimal source requires balancing cost considerations against quality assurance and regulatory requirements, ensuring that supply chains are resilient and compliant with regional standards.


Key Takeaways

  • Major bulk Bethanechol Chloride API suppliers are located in India, China, and select European regions, each with distinct advantages.
  • Ensuring GMP compliance and obtaining detailed Certificates of Analysis is critical for quality assurance.
  • Diversifying suppliers and establishing robust partnerships mitigate supply risks and ensure consistent product availability.
  • Monitoring evolving regulations and sustainability standards is vital for long-term sourcing strategies.
  • Suppliers with proven regulatory track records simplify approval processes and reduce compliance barriers.

FAQs

1. What are the primary regions for sourcing Bethanechol Chloride API?
India, China, and Europe are the leading regions, with India and China providing more cost-effective options and Europe focusing on high-quality standards.

2. How can I verify the quality of a Bethanechol Chloride API supplier?
Request GMP certificates, Certificates of Analysis, and perform audits or third-party inspections to ensure adherence to quality standards.

3. Are there regulatory concerns associated with sourcing APIs from China and India?
While many suppliers maintain stringent standards, due diligence is essential. Ensure suppliers have relevant certifications (GMP, ISO) and good regulatory reputations.

4. What are the key factors when selecting a Bethanechol Chloride API supplier?
Quality compliance, regulatory approval, supply capacity, lead times, pricing, and sustainability practices.

5. Is there an increasing trend towards sustainable API manufacturing?
Yes. The industry is favoring suppliers adopting environmentally friendly processes, reducing waste, and minimizing ecological impact.


References

[1] U.S. Food and Drug Administration (FDA). API Manufacturing and Quality Control Standards. (2022).
[2] Indian Pharmaceutical Alliance. API Market Reports. (2022).
[3] European Federation of Pharmaceutical Industries and Associations (EFPIA). API Production Guidelines. (2022).
[4] IMS Health. Global API Market Insights. (2022).
[5] Chinese Pharmaceutical Industry Association. API Supply Chain Analyses. (2022).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.